>>17084997
SNSS isn't going to cure cancer. It is, however, going to treat people with severe, drug resistant blood cancer, and it is going to save lives. Also it will make a lot of money. Also it will make me, specifically, a lot of money. Very soon now. It's 3 main competitors, ARQL, LOXO, and APTO, look what happened to all 3 of them within the last few months when their tests showed results earlier than SNSS because SNSS decided to be super methodical about safety. But we're about to hit that efficacy finish line, and frankly I think we'll find out this month.